Hangzhou Converd Co., Ltd.
Clinical trials sponsored by Hangzhou Converd Co., Ltd., explained in plain language.
-
Engineered virus teams up with immune drug to fight tough cancers
Disease control Recruiting nowThis study is testing a new two-part treatment for advanced solid tumors that have not responded to standard therapies. It combines a specially engineered virus designed to attack cancer cells with a drug that helps the immune system fight cancer. The main goals are to see if thi…
Phase: NA • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Engineered virus targets tough pancreatic tumors in new trial
Disease control Recruiting nowThis trial is testing a new treatment called hV01, which is a specially modified virus designed to infect and kill pancreatic cancer cells. It is for adults with advanced pancreatic cancer that has not responded to standard therapies. The virus is injected directly into the tumor…
Phase: PHASE2 • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC